BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14632572)

  • 1. CD117, but not lysozyme, is positive in cutaneous plasmacytoma.
    Bayer-Garner IB; Schwartz MR; Lin P; Smoller BR
    Arch Pathol Lab Med; 2003 Dec; 127(12):1596-8. PubMed ID: 14632572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma.
    Chen J; Yanuck RR; Abbondanzo SL; Chu WS; Aguilera NS
    Arch Pathol Lab Med; 2001 Nov; 125(11):1448-52. PubMed ID: 11698000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytoma.
    Bayer-Garner IB; Joseph L; Sanderson RD; Smoller BR
    J Cutan Pathol; 2003 Jan; 30(1):18-22. PubMed ID: 12534799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas.
    Bayer-Garner IB; Prieto VG; Smoller BR
    Arch Pathol Lab Med; 2004 Jun; 128(6):645-8. PubMed ID: 15163236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of lysozyme in multiple myeloma.
    al Safadi L; Hellerich U; Schaefer HE
    Pathol Res Pract; 1994 Jun; 190(6):578-83. PubMed ID: 7527145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
    Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
    Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple primary cutaneous plasmacytomas: an unusual presentation.
    Uçmak D; Meltem Akkurt Z; Türkçü G; Harman M; Sinan Dal M; Uçmak F
    J Cutan Med Surg; 2014 Oct; 18(5):361-4. PubMed ID: 25187000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extramedullary plasmacytoma in cardiac transplant recipients.
    Pacheco TR; Hinther L; Fitzpatrick J
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S255-8. PubMed ID: 14576645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry for CD117 (KIT) is effective in distinguishing cutaneous adnexal tumors with apocrine/eccrine or sebaceous differentiation from other epithelial tumors of the skin.
    Goto K
    J Cutan Pathol; 2015 Jul; 42(7):480-8. PubMed ID: 25864700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcoma.
    Amador-Ortiz C; Hurley MY; Ghahramani GK; Frisch S; Klco JM; Lind AC; Nguyen TT; Hassan A; Kreisel FH; Frater JL
    J Cutan Pathol; 2011 Dec; 38(12):945-53. PubMed ID: 22050091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma.
    Garcia JJ; Kramer MJ; Mackey ZB; O'Donnell RJ; Horvai AE
    Arch Pathol Lab Med; 2006 Mar; 130(3):343-8. PubMed ID: 16519562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCR-based clonality analysis of antigen receptor gene rearrangements in canine cutaneous plasmacytoma.
    Takanosu M; Okada K; Kagawa Y
    Vet J; 2018 Nov; 241():31-37. PubMed ID: 30340657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient of extramedullary cutaneous and gingival plasmacytomas.
    Lou Y; Jin J; Tong X
    Eur J Haematol; 2005 Aug; 75(2):171. PubMed ID: 16000135
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas.
    Kato N; Kimura K; Yasukawa K; Aikawa K
    J Dermatol; 1999 Sep; 26(9):587-94. PubMed ID: 10535253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary cutaneous plasmacytoma. A case report and review of the literature].
    Müller RP; Krausse S; Rahlf G
    Hautarzt; 1990 Apr; 41(4):232-5. PubMed ID: 2192999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of a primary cutaneous plasmacytoma presenting in adolescence.
    Koletsa T; Patsatsi A; Kostopoulos I; Kartsios C; Korantzis I; Sotiriadis D
    Am J Dermatopathol; 2012 Jul; 34(5):537-40. PubMed ID: 22421294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic cutaneous plasmacytoma presenting as a perianal giant mass.
    Alvarez-Twose I; Vano-Galvan S; Calvo-Villas JM; Carreter E; Piqué E; Palacios S
    Dermatol Online J; 2008 Sep; 14(9):17. PubMed ID: 19061599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the expression of C-kit (CD117) in ependymomas and oligodendrogliomas.
    Zavalhia LS; Romitti M; Netto GC; dos Santos GT; Meurer RT; Hilbig A; Michalowski MB; Barbosa Coutinho LM; de Castro Ribeiro M
    Dis Markers; 2012; 33(2):61-8. PubMed ID: 22846208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of multiple myeloma associated with extramedullary cutaneous plasmacytoma and pyoderma gangrenosum.
    Yoon YH; Cho WI; Seo SJ
    Int J Dermatol; 2006 May; 45(5):594-7. PubMed ID: 16700800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD117 (KIT) is a useful marker in the diagnosis of plasmablastic plasma cell myeloma.
    Marks E; Shi Y; Wang Y
    Histopathology; 2017 Jul; 71(1):81-88. PubMed ID: 28226184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.